Core Laboratories Inc. $CLB Shares Sold by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System lowered its stake in shares of Core Laboratories Inc. (NYSE:CLB) by 13.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,665 shares of the oil and gas company’s stock after selling 2,177 shares during the period. Maryland State Retirement & Pension System’s holdings in Core Laboratories were worth $205,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of CLB. Assetmark Inc. boosted its position in shares of Core Laboratories by 92.5% in the first quarter. Assetmark Inc. now owns 2,887 shares of the oil and gas company’s stock worth $43,000 after acquiring an additional 1,387 shares during the last quarter. Tower Research Capital LLC TRC grew its position in Core Laboratories by 843.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company’s stock valued at $57,000 after acquiring an additional 2,936 shares during the period. BNP Paribas Financial Markets purchased a new position in shares of Core Laboratories in the 4th quarter worth about $123,000. XTX Topco Ltd acquired a new position in Core Laboratories during the first quarter valued at approximately $155,000. Finally, Sherbrooke Park Advisers LLC acquired a new position in shares of Core Laboratories during the 4th quarter valued at $176,000. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Core Laboratories Price Performance

Shares of CLB opened at $10.3850 on Wednesday. The firm has a market capitalization of $486.95 million, a price-to-earnings ratio of 16.75, a price-to-earnings-growth ratio of 3.17 and a beta of 1.41. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.70 and a current ratio of 2.27. The stock’s fifty day moving average is $11.66 and its 200-day moving average is $12.89. Core Laboratories Inc. has a one year low of $9.72 and a one year high of $21.83.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.01. Core Laboratories had a net margin of 5.73% and a return on equity of 14.15%. The business had revenue of $130.16 million during the quarter, compared to analysts’ expectations of $129.19 million. During the same period last year, the firm posted $0.22 earnings per share. The business’s revenue was down .3% on a year-over-year basis. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS. Equities analysts anticipate that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, August 25th. Stockholders of record on Monday, August 4th will be issued a dividend of $0.01 per share. The ex-dividend date is Monday, August 4th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.4%. Core Laboratories’s payout ratio is currently 6.45%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CLB. Stifel Nicolaus decreased their target price on shares of Core Laboratories from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Wednesday, July 16th. Zacks Research raised shares of Core Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, August 15th. Wall Street Zen raised Core Laboratories from a “sell” rating to a “hold” rating in a report on Saturday, July 26th. Finally, Citigroup decreased their price objective on shares of Core Laboratories from $16.00 to $13.00 and set a “neutral” rating for the company in a report on Tuesday, May 13th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $12.50.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.